A dipeptidyl peptidase inhibitor, evogliptin, directly prevents nephrin loss and podocyte damage via posttranscriptional regulation. (2020)

Record Type:: Journal Article
Title:: A dipeptidyl peptidase inhibitor, evogliptin, directly prevents nephrin loss and podocyte damage via posttranscriptional regulation. (2020)
Main Title:: A dipeptidyl peptidase inhibitor, evogliptin, directly prevents nephrin loss and podocyte damage via posttranscriptional regulation
Authors:: YH, Cheong
H, Park
IH, Jung
YN, Chae
TH, Kim
BR, Lee
MK, Kim
Is Part Of:: Diabetes updates. Volume 6:Number 1(2020)
Journal:: Diabetes updates
Issue:: Volume 6:Number 1(2020)
Issue Display:: Volume 6, Issue 1 (2020)
Year:: 2020
Volume:: 6
Issue:: 1
Issue Sort Value:: 2020-0006-0001-0000
Page Start:
Page End:
Publication Date:: 2020
Subjects:: Diabetes -- Periodicals
616.462005
Journal URLs:: https://www.oatext.com/Diabetes-Updates-DU.php ↗
DOI:: 10.15761/DU.1000139 ↗
Languages:: English
ISSNs:: 2631-5483
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library HMNTS - ELD Digital store
Ingest File:: 13624.xml